These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3299110)

  • 1. [Immunosuppressive treatment in multiple sclerosis].
    Minderhoud JM; Prange AJ; Luijckx GJ
    Ned Tijdschr Geneeskd; 1987 May; 131(22):966-7. PubMed ID: 3299110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].
    Aimard G; Confavreux C; Trouillas P; Devic M
    Rev Neurol (Paris); 1978 Mar; 134(3):215-22. PubMed ID: 360353
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current studies of the effects of immunosuppressive agents on multiple sclerosis].
    Minderhoud JM
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):99-100. PubMed ID: 2646546
    [No Abstract]   [Full Text] [Related]  

  • 6. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term therapeutic trials and multiple sclerosis: a wager?].
    Confavreux C
    Rev Neurol (Paris); 1983; 139(6-7):431-7. PubMed ID: 6412341
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiple sclerosis--current status of therapy].
    Reichel D; Kölmel HW
    Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary reports on a therapeutical trial in multiple sclerosis.
    Floris V; Spadaro M; Tilia G
    Riv Neurol; 1987; 57(3):185-8. PubMed ID: 3313667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].
    Patzold U; Haller P; Haas J; Pocklington P; Deicher H
    Nervenarzt; 1978 May; 49(5):285-94. PubMed ID: 673085
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 14. [Side effects of azathioprine (Imurel). Apropos of 313 patients treated for multiple sclerosis. Review of the literature].
    Ventre JJ; Guillot M; Confavreux C; Evreux JC; Aimard G
    Therapie; 1985; 40(3):195-202. PubMed ID: 4012666
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive treatment in multiple sclerosis].
    Vermeulen M; Zegerius L; van Crevel H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):93-6. PubMed ID: 3821989
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary results of imurek treatment of multiple sclerosis].
    Müller J; Kreiner R; Sauermann W
    Psychiatr Neurol Med Psychol (Leipz); 1976 Dec; 28(12):755-61. PubMed ID: 1019278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Further experiences with the Imurek treatment in multiple sclerosis].
    Müller J; Sauermann W; Kreiner R
    Psychiatr Neurol Med Psychol (Leipz); 1981 Sep; 33(9):527-31. PubMed ID: 7302005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
    Tourtellotte WW; Syndulko K; Baumhefner RW; Shapshak P; Osborne M
    Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
    [No Abstract]   [Full Text] [Related]  

  • 20. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
    Oger J; Cloarec L; Chatel M; Sabouraud O
    Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.